MAP3K8 anticorps (pThr290)
Aperçu rapide pour MAP3K8 anticorps (pThr290) (ABIN2625110)
Antigène
Voir toutes MAP3K8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pThr290
-
Specificité
- Recognizes endogenous levels of TPL2 (pT290) protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
KLH-conjugated synthetic peptide encompassing a sequence within the central region of human TPL2 (pT290).
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Autre désignation
- MAP3K8 / TPL2
-
Sujet
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
ID gène
- 1326
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling
Antigène
-